StockVS

NASDAQ · Medical Distribution · USD

Synergy CHC Corp. (SNYR) Stock Analysis

Synergy CHC Corp. (SNYR) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.

SNYR

$0.10

−$0.01 (−6.36%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SNYR with… →

SNYR Key Statistics

As of Sep 4, 2026
Trading
Open
$0.11
Previous Close
$0.11
Day's Range
0.10–0.11
52-Week Range
0.08–2.96
Volume
624.80K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.64
Valuation
Market Cap
$1.53M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
0.68
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.06
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.51
Financials (FY)
Revenue (FY)
$30.38M−12.78%
Net Income (FY)
−$12.34M−680.77%
Profit marginThe share of revenue left as profit after all costs and taxes.
−56.98%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
14.90M
1-Year Return
−95.60%
Dividend and dates
Avg Volume
4.88M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SNYR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−94.46%
2025−57.73%
2024 (partial year)−51.11%

As of September 4, 2026.

SNYR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$30.38M−$12.34M−40.6%
2024$34.83M$2.12M6.1%
2023$42.78M$6.34M14.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$30.38M$20.30M−$1.80M−$12.34M−40.6%
2024$34.83M$23.64M$5.80M$2.12M6.1%
2023$42.78M$32.08M$10.81M$6.34M14.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SNYR Valuation vs Medical Distribution Median

Median of 13 stocks
MetricSNYRMedical Distribution medianvs median
P/S ratio0.060.360.2x the median
Profit margin−56.98%−4.03%53.0 pts below

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Synergy CHC Corp. (SNYR) carries a market capitalisation of $1.53M. It is classified in the Medical Distribution industry, within the Healthcare sector. Headcount on file is 28.

SNYR last closed at $0.10 on September 4, 2026. That is −$0.01 (−6.36%) against the previous close. Over the past 52 weeks the price has ranged from $0.08 to $2.96. The latest close sits 25.61% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $30.38M. Against the prior fiscal year total of $34.83M, that is a change of −12.78%. The same year closed with a net loss of $12.34M. Profit margin runs at −56.98%. That is 53 percentage points below the Medical Distribution median of −4.03%. Trailing earnings per share are −1.51.

Across the 3 fiscal years on file, revenue moves from $42.78M in 2023 to $30.38M in 2025. Of those 3 years, 2 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 0.68. The price-to-sales ratio is 0.06. On price-to-sales that is 0.2 times the Medical Distribution median of 0.36. 13 Medical Distribution companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −95.60%. The stored price history starts on October 23, 2024, and the total return since then is −98.86%. Beta against the wider market is reported at 0.64. Daily returns over the trailing 1 year annualize to a volatility of 104.87%.

Growth & Income

The record shows no dividend for SNYR.

So far in 2026 the price is −94.46%. The record holds one complete calendar year, 2025, which returned −57.73%.

Peer Comparison

Synergy CHC Corp. (SNYR) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Synergy CHC Corp. SNYR $1.53M
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Cardinal Health, Inc. CAH $57.49B 34.4

The Medical Distribution industry average P/E ratio is 25.8x. Synergy CHC Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

View all Medical Distribution stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Synergy CHC Corp.

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.

Visit website →